These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Methylnaltrexone for the Treatment of Constipation in Critically Ill Children. López J; Fernández SN; Santiago MJ; Urbano J; González R; Fernández-Llamazares C; López-Herce J J Clin Gastroenterol; 2016 Apr; 50(4):351-2. PubMed ID: 26950234 [No Abstract] [Full Text] [Related]
3. An overview of constipation and newer therapies. Enck RE Am J Hosp Palliat Care; 2009; 26(3):157-8. PubMed ID: 19531698 [No Abstract] [Full Text] [Related]
5. The role of methylnaltrexone in opioid-induced constipation. Hellwig TR; Pottebaum AA S D Med; 2013 Oct; 66(10):425, 427. PubMed ID: 24244983 [No Abstract] [Full Text] [Related]
6. Methylnaltrexone (Relistor) for opioid induced constipation. Med Lett Drugs Ther; 2008 Aug; 50(1292):63-4. PubMed ID: 18688204 [No Abstract] [Full Text] [Related]
8. Methylnaltrexone for opioid-induced constipation in advanced illness. Sanz Rubiales A; del Valle Rivero ML N Engl J Med; 2008 Sep; 359(10):1070-1; author reply 1071. PubMed ID: 18768955 [No Abstract] [Full Text] [Related]
9. The Food and Drug Administration approves methylnaltrexone bromide for opioid-induced constipation. Lang L Gastroenterology; 2008 Jul; 135(1):6. PubMed ID: 18549816 [No Abstract] [Full Text] [Related]
10. Treating opioid-induced constipation with methylnaltrexone bromide. Kyle G Nurs Times; 2009 Feb 3-9; 105(4):25. PubMed ID: 19263773 [No Abstract] [Full Text] [Related]
11. Management of constipation in patients receiving palliative care. Cayley WE Am Fam Physician; 2011 Dec; 84(11):1227-8. PubMed ID: 22150655 [No Abstract] [Full Text] [Related]
12. Drug approvals: '08 in review. Methylnaltrexone (Relistor). Laustsen G; Carrillo F; Johnson J; Smith C Nurse Pract; 2009 Feb; 34(2):31. PubMed ID: 19155882 [No Abstract] [Full Text] [Related]
13. Methylnaltrexone for opioid-induced constipation in pediatric oncology patients. Rodrigues A; Wong C; Mattiussi A; Alexander S; Lau E; Dupuis LL Pediatr Blood Cancer; 2013 Oct; 60(10):1667-70. PubMed ID: 23766091 [TBL] [Abstract][Full Text] [Related]
14. Methylnaltrexone: new drug. Opiate-induced constipation: barely more effective than placebo. Prescrire Int; 2009 Aug; 18(102):158. PubMed ID: 19743572 [No Abstract] [Full Text] [Related]
16. Methylnaltrexone for opioid-induced constipation. Belavic JM Nurse Pract; 2009 Mar; 34(3):6-7. PubMed ID: 19240629 [No Abstract] [Full Text] [Related]
17. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction. Baker DE Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269 [TBL] [Abstract][Full Text] [Related]
18. Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient. Lee JM; Mooney J Clin J Pain; 2012 May; 28(4):338-41. PubMed ID: 21876436 [TBL] [Abstract][Full Text] [Related]
20. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects. Yuan CS J Support Oncol; 2004; 2(2):111-7; discussion 119-22. PubMed ID: 15328815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]